Anzeige
Mehr »
Login
Dienstag, 07.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Warum der Warren Buffett des Bergbaus alles auf diese Aktie setzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 870747 | ISIN: US5949181045 | Ticker-Symbol: MSF
Tradegate
07.01.25
21:59 Uhr
408,35 Euro
-3,20
-0,78 %
1-Jahres-Chart
MICROSOFT CORPORATION Chart 1 Jahr
5-Tage-Chart
MICROSOFT CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
408,95409,3523:00
408,05408,6022:02
ACCESSWIRE
184 Leser
Artikel bewerten:
(1)

QNX Collaborates with Microsoft to Drive Software-Defined Vehicle Innovations

Finanznachrichten News

QNX SDP 8.0 coming soon to Microsoft Azure

LAS VEGAS, NV / ACCESSWIRE / January 6, 2025 / CES: QNX, a division of BlackBerry Limited (NYSE:BB)(TSX:BB) today announced it is collaborating with Microsoft to make it easier for automakers to build, test, and refine software within the cloud, accelerating the development of Software-Defined Vehicles (SDVs).

As part of the collaboration, the QNX® Software Development Platform (SDP) 8.0 will soon be available on Microsoft Azure, providing developers with a robust and proven cloud environment to create, test and integrate the software that will power next-generation automotive and Internet of Things applications. Looking to the future, the two companies intend to work together to extend the solution to include the QNX® Hypervisor and the new QNX® Cabin, an innovative reference architecture that allows OEMs to develop hardware agnostic digital cockpits using the cloud.

"A cloud-first, shift-left strategy is becoming a requirement for any competitive development infrastructure," said John Wall, Chief Operating Officer and Head of Product, Engineering and Services at QNX. "Together with Microsoft, we are looking at innovative ways to bring Microsoft Azure AI in to support cutting-edge technology early in the development cycle. This approach accelerates development timelines and minimizes risks, allowing automakers to leverage the scale and development velocity inherent to the cloud. Together, we're paving the way for the next generation of connected and autonomous vehicles."

"This collaboration bolsters our commitment to empower the automotive industry with cutting-edge technology to accelerate innovation," said Dayan Rodriguez, Corporate Vice President, Manufacturing & Mobility, Microsoft. "By combining the strengths of Microsoft Azure and QNX, we're enabling OEMs to deliver on the promise of the Software-Defined Vehicle."

At CES 2025, QNX will demonstrate how developers can benefit from the QNX Software Development Platform (SDP) 8.0 on Azure for early testing and validation of software virtually, helping to ensure that potential issues are identified and resolved earlier in the development process.

QNX's complete suite of automotive offerings will be on display at CES from January 7 - 11, 2025, at the Las Vegas Convention Center. Visit QNX at Booth #4224 in the West Hall or schedule a meeting with a spokesperson here.

About BlackBerry

BlackBerry (NYSE:BB)(TSX:BB) provides enterprises and governments the intelligent software and services that power the world around us. Based in Waterloo, Ontario, the company's high-performance foundational software enables major automakers and industrial giants alike to unlock transformative applications, drive new revenue streams and launch innovative business models, all without sacrificing safety, security, and reliability. With a deep heritage in Secure Communications, BlackBerry delivers operational resiliency with a comprehensive, highly secure, and extensively certified portfolio for mobile fortification, mission-critical communications, and critical events management. The company is also a pioneer in leveraging Artificial Intelligence and Machine Learning to deliver advanced cybersecurity solutions to its customers.

About QNX

QNX, a division of BlackBerry Limited (NYSE:BB)(TSX:BB), enhances the human experience and amplifies technology-driven industries, providing a trusted foundation for software-defined businesses to thrive. The business leads the way in delivering safe and secure operating systems, hypervisors, middleware, solutions, and development tools, along with support and services delivered by trusted embedded software experts. QNX® technology has been deployed in the world's most critical embedded systems, including more than 255 million vehicles on the road today. QNX® software is trusted across industries including automotive, medical devices, industrial controls, robotics, commercial vehicles, rail, and aerospace and defense. Founded in 1980, QNX is headquartered in Ottawa, Canada. Learn more at qnx.com.

©2025 BlackBerry Limited. Trademarks, including but not limited to BLACKBERRY and EMBLEM Design, QNX and the QNX logo design are the trademarks or registered trademarks of BlackBerry Limited, and the exclusive rights to such trademarks are expressly reserved. All other trademarks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services.

Media Contacts:

BlackBerry Media Relations
+1 (519) 597-7273
mediarelations@BlackBerry.com

SOURCE: QNX



View the original press release on accesswire.com

© 2025 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.